# A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

> **NCT07525375** · PHASE2 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 69 (estimated)

## Conditions studied

- Asthma

## Interventions

- **COMBINATION_PRODUCT:** GP MDI
- **COMBINATION_PRODUCT:** BFF MDI
- **COMBINATION_PRODUCT:** Placebo MDI

## Key facts

- **NCT ID:** NCT07525375
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-14
- **Primary completion:** 2029-05-23
- **Final completion:** 2029-05-23
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07525375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07525375, "A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07525375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*